Synchron
Synchron
Claim
Synchron is a neurotechnology company developing an endovascular brain-computer interface (BCI) designed to restore functionality in patients with severe paralysis. The clinical-stage company is developing a neuroprosthesis to restore motor signaling to control digital devices and autonomy for individuals with motor impairment.Synchron is a neurotechnology company developing an endovascular brain-computer interface (BCI) desi Show More
Alpha Score
$ 325.00 M
Alpha Score
78.0
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0